{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/vitiligo/background-information/definition/","result":{"pageContext":{"chapter":{"id":"c23ed46f-6f85-51ef-9f34-aea63f9aea9e","slug":"definition","fullItemName":"Definition","depth":2,"htmlHeader":"<!-- begin field ce9c46f6-a323-43be-95a2-63995827040c --><h2>What is it?</h2><!-- end field ce9c46f6-a323-43be-95a2-63995827040c -->","summary":"","htmlStringContent":"<!-- begin item 791100a2-f239-4a64-a207-eb49ec6c15e9 --><!-- begin field 6b7f5121-87ac-4a7b-8aed-7c37e61e8edf --><ul><li><strong>Vitiligo is an acquired, chronic depigmentation disorder characterized by selective loss of melanocytes and a chalky white appearance of affected areas of skin (and sometimes hair).</strong> It is classified into two subtypes according to its distribution and extent [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Gawkrodger, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Ezzedine, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">de Menezes, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Bergqvist, 2020</a>].<ul><li><strong>Non-segmental vitiligo (or 'vitiligo' used as an umbrella term) is the more common form,</strong> accounting for 85–90% of people with vitiligo. It has a non-dermatomal distribution and may be divided into different forms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Ezzedine, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">de Menezes, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Ezzedine, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Bergqvist, 2020</a>]:<ul><li>Focal vitiligo — a small, isolated, depigmented lesion without an obvious segmental distribution pattern, and which has not evolved after a period of 1–2 years.</li><li>Acrofacial vitiligo — depigmented macules limited to the distal extremities and/or the face (particularly around the orifices). It may subsequently become more widespread and generalized. The 'lip-tip' variety describes lesions that are restricted to the cutaneous lips and distal tips of the digits.</li><li>Mucosal vitiligo — located on the oral and/or genital mucosa.</li><li>Generalized vitiligo — bilateral, often symmetrical, depigmented macules or patches occurring in a random distribution over the entire body surface. It often affects areas that tend to experience pressure, friction, and/or trauma. It may begin in childhood or early adulthood.</li><li>Universal vitiligo — complete or nearly complete depigmentation of the skin (80–90% of the body surface area). It is usually preceded by generalized vitiligo.</li><li>Follicular vitiligo — depigmented body hairs caused by involvement of the melanocyte follicular reservoir.</li><li>Mixed vitiligo — where segmental and non-segmental forms may co-exist in one person.</li><li>Unclassified vitiligo — describes isolated mucosal involvement and persistent focal vitiligo.</li></ul></li><li><strong>Segmental vitiligo is classified separately from all other forms of vitiligo </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Ezzedine, 2012</a>]<strong>.</strong> It is less common, typically has an earlier age of onset, and affects 20–30% of children and about 5% of adults with vitiligo [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Gawkrodger, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Ezzedine, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">de Menezes, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vitiligo/references/\">Bergqvist, 2020</a>].<ul><li>It usually has a dermatomal distribution, affecting part or all of a single dermatome, and is usually unilateral and limited to one segment. It may involve the melanocytes of hair follicles, leading to depigmentation of affected hairs. More rarely, it may affect several segments (which may be unilateral or bilateral), and may affect larger areas delineated by Blaschko's lines (invisible lines representing the developmental growth pattern of the skin).</li></ul></li></ul></li></ul><!-- end field 6b7f5121-87ac-4a7b-8aed-7c37e61e8edf --><!-- end item 791100a2-f239-4a64-a207-eb49ec6c15e9 -->","topic":{"id":"72501cc1-fbf6-5c3a-bfc1-1a2d865f7dff","topicId":"85a32b0f-cf7a-41c9-9dd8-caed21004663","topicName":"Vitiligo","slug":"vitiligo","lastRevised":"Last revised in April 2020","chapters":[{"id":"237f05d1-6751-5abf-98b0-af49db55e1b3","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e51e2938-3e89-53a6-9251-b0376a90be4d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"5c590af0-29e5-5be3-958d-02f67350d529","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"aee2331c-c78c-5c0d-ba9a-c974cfb039ae","slug":"changes","fullItemName":"Changes"},{"id":"8afc6e46-c250-5eb3-85a1-355d3e18ee65","slug":"update","fullItemName":"Update"}]},{"id":"78bbc5cd-9e73-55fb-b421-d718417be14a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"1a4f8e76-7634-54ba-8849-3051a448dccc","slug":"goals","fullItemName":"Goals"},{"id":"65dbcf54-b53e-54e8-a2fe-a07b8aae49f2","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"ba868062-b333-5694-90cb-1b24ed0d9c11","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1912341a-6cf7-5d2a-b20d-cb4f55308c36","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"05992da2-cc78-5880-8307-5a5f8e4cc4da","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"30dc5858-bfd0-5918-b331-9067d9743f12","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"33d1fc44-e925-5b20-982d-7e60d75465ea","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c23ed46f-6f85-51ef-9f34-aea63f9aea9e","slug":"definition","fullItemName":"Definition"},{"id":"cfca1785-6f25-546b-8fba-a9bb5ec8bc4f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1c68db6d-01f9-5407-b229-ad9ba72d53b1","slug":"causes","fullItemName":"Causes"},{"id":"def00a0c-fcf5-5066-b8b6-d4197121b345","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"4b6c885f-0d2d-5b2c-abeb-495372e63081","slug":"complications","fullItemName":"Complications"},{"id":"63ac95a4-7b80-5aef-bf7b-cc1b8b812a1c","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"9b1dd44e-152a-5b47-8bbd-a07a6000032f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"465324e6-d6e2-5263-8c5d-9368e36b2d89","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"ebc547bc-2b3a-55f8-a703-fff4f5d4f309","slug":"assessment","fullItemName":"Assessment"},{"id":"dea3c9af-e347-5a61-8a6e-852afbca1f6b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"674a723c-f8af-5b44-b6fc-6d46ad281431","fullItemName":"Management","slug":"management","subChapters":[{"id":"d85da703-7350-5165-a4eb-3697e45db487","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"8ddf3c8a-0168-521b-a940-e841ebe05935","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"0f441642-e226-5709-89d2-b4f6eeee7a85","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d538aa6d-327c-503c-b574-69a24bbfd9f0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c5bed09a-eccb-5abe-8ff1-63f178d8c28c","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f56b39ed-360e-5ae6-9103-c21bb5e9862d","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"ba61933a-4f62-5bb3-988b-9749f78e6265","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"31c2bb80-d9f1-5095-b859-2ad42da47934","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a43f071b-fb92-55e3-a42d-348c5fd48924","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"33d1fc44-e925-5b20-982d-7e60d75465ea","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}